With 1.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.5 million shares. The 52-week range on DOCN shows that it touched its highest point at $47.02 and its lowest point at $25.45 during that stretch. It currently has a 1-year price target of $38.00. Beta for the stock currently stands at 1.78.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DOCN was down-trending over the past week, with a drop of -2.80%, but this was down by -8.25% over a month. Three-month performance dropped to -23.65% while six-month performance fell -26.71%. The stock lost -27.47% in the past year, while it has lost -17.38% so far this year. A look at the trailing 12-month EPS for DOCN yields 1.09 with Next year EPS estimates of 2.02. For the next quarter, that number is 0.47. This implies an EPS growth rate of 1.58% for this year and 3.45% for next year.
Float and Shares Shorts:
At present, 91.22 million DOCN shares are outstanding with a float of 64.97 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DOCN since 9 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.85754 being high and $1.6986 being low. For DOCN, this leads to a yearly average estimate of $1.74827.
